Sage Journals: Discover world-class research

Retricted access

Research article

First published 2017-6

Decreased soluble IFN-β receptor (sIFNAR2) in multiple sclerosis patients: A potential serum diagnostic biomarker

Teresa Órpez-Zafra, Jose Pavía, Isaac Hurtado-Guerrero [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 1993-10

Modification of Soluble Immunological Parameters during Treatment with Interleukin-2

I. Abbate, M. Correale, M.D. Musci [...]

The International Journal of Biological Markers

Retricted access

Other

First published 2006-09

Serum immunologic markers in multiple sclerosis patients on continuous combined therapy with beta-interferon 1a,prednisone and azathioprine

C A Braun Hashemi, Y CQ Zang, J A Arbona [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2011-8

Cross-talk of the related bioactivity mediators in serum after injection of soluble TNF-α receptor on silicosis model of rats

Hong-Sheng Gao, Rong Xue, Peng Ding [...]

Toxicology and Industrial Health

Retricted access

Research article

First published 1999-02

Serum Levels of Tumor Necrosis Factor-alpha,Interleukin-1,and Interferon-gamma in beta-Thalassemia/HbE and Their Clinical Significance

W. Wanachiwanawin, E. Wiener, U. Siripanyaphinyo [...]

Journal of Interferon & Cytokine Research

Retricted access

Research article

First published 2010-05

Interleukin 7 Receptor Alpha Chain Haplotypes Vary in Their Influence on Multiple Sclerosis Susceptibility and Response to Interferon Beta

Edwin Hoe, Fiona McKay, Steven Schibeci [...]

Journal of Interferon & Cytokine Research

Retricted access

Research article

First published 1993-10

Immunotherapy with Low-Dose Subcutaneous Interleukin-2 plus Beta-Interferon as a Second-Line Therapy for Metastatic Colorectal Carcinoma

Sandro Barni, Paolo Lissoni, Antonio Ardizzola [...]

Tumori Journal

Search results

Decreased soluble IFN-β receptor (sIFNAR2) in multiple sclerosis patients: A potential serum diagnostic biomarker

Modification of Soluble Immunological Parameters during Treatment with Interleukin-2

Serum immunologic markers in multiple sclerosis patients on continuous combined therapy with beta-interferon 1a,prednisone and azathioprine

Cross-talk of the related bioactivity mediators in serum after injection of soluble TNF-α receptor on silicosis model of rats

Serum Levels of Tumor Necrosis Factor-alpha,Interleukin-1,and Interferon-gamma in beta-Thalassemia/HbE and Their Clinical Significance

Interleukin 7 Receptor Alpha Chain Haplotypes Vary in Their Influence on Multiple Sclerosis Susceptibility and Response to Interferon Beta

Immunotherapy with Low-Dose Subcutaneous Interleukin-2 plus Beta-Interferon as a Second-Line Therapy for Metastatic Colorectal Carcinoma